Biochemical characterization of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 4, 2014, Pages 532-537

  Del Prete, Sonia ^a   De Luca, Viviana ^a   Vullo, Daniela ^b   Scozzafava, Andrea ^b   Carginale, Vincenzo ^a   Supuran, Claudiu T ^b   Capasso, Clemente ^a  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

CO2 hydration; Enzyme kinetic; Metalloenzymes; Periodontitis; carbonic anhydrase

Indexed keywords

ACID; CARBONATE DEHYDRATASE; GAMMA CARBONIC ANHYDRASE; POLYPEPTIDE; RECOMBINANT ENZYME; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; CHEMICAL ANALYSIS; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME PURIFICATION; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOSARCINA THERMOPHILA; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TEMPERATURE; THERMOSTABILITY; THERMOSYNECHOCOCCUS ELONGATUS; CHEMISTRY; ENZYME STABILITY; ENZYMOLOGY; ISOLATION AND PURIFICATION; KINETICS; METABOLISM;

CARBONIC ANHYDRASES; ENZYME STABILITY; KINETICS; PORPHYROMONAS GINGIVALIS; RECOMBINANT PROTEINS; TEMPERATURE;

EID: 84904362687     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2013.822371     Document Type: Article

References (55)

1. Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81.
2. Supuran CT. Bacterial carbonic anhydrases as drug targets: Toward novel antibioticŞ. Front Pharmacol 2011;2:1-6.
3. Joseph P, Ouahrani-Bettache S, Montero JL, et al. A new betacarbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. Bioorg Med Chem 2011;19:1172-8.
4. Krungkrai J, Supuran CT. The alpha-carbonic anhydrase from the malaria parasite and its inhibition. Curr Pharm Des 2008;14:631-40.
5. Krungkrai J, Scozzafava A, Reungprapavut S, et al. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: Towards antimalarials with a novel mechanism of action?. Bioorg Med Chem 2005;13:483-9.
6. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74.
7. Supuran CT. Indisulam: An anticancer sulfonamide in clinical development. Expert Opin Investig Drugs 2003;12:283-7.
8. Supuran CT. Carbonic anhydrases as drug targets - An overview. Curr Top Med Chem 2007;7:825-33.
9. Supuran CT. Antiepileptic activity of zonisamide on hippocampal CA3 neurons does not depend on carbonic anhydrase inhibition. Epilepsy Res 2008;82:109.
10. Supuran CT. Carbonic anhydrase inhibition/activation: Trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233-45.
11. Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents. Med Res Rev 2003;23:535-58.
12. Buck J, Levin LR. Physiological sensing of carbon dioxide/bicarbonate/pH via cyclic nucleotide signaling. Sensors (Basel) 2011;11:2112-28.
13. Tresguerres M, Buck J, Levin LR. Physiological carbon dioxide, bicarbonate, and pH sensing. Pflugers Arch 2010;460:953-64.
14. Supuran CT. Carbonic anhydrases - An overview. Curr Pharm Des 2008;14:603-14.
15. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-50.
16. Alvarez BV, Loiselle FB, Supuran CT, et al. Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium/bicarbonate co-transporter. Biochemistry 2003;42:12321-9.
17. Di Fiore A, Maresca A, Alterio V, et al. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II. Chem Commun (Camb) 2011;47:11636-8.
18. Avvaru BS, Wagner JM, Maresca A, et al. Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. Bioorg Med Chem Lett 2010;20:4376-81.
19. Heylings JR, Garner A, Flemstrom G. The gastric "mucusbicarbonate" barrier: Effect of luminal acid on HCO3(-) transport by amphibian fundic mucosa in vitro. Adv Exp Med Biol 1982;144: 183-5.
20. Bourgogne A, Thomson LC, Murray BE. Bicarbonate enhances expression of the endocarditis and biofilm associated pilus locus, ebpR-ebpABC, in Enterococcus faecalis. BMC Microbiol 2010; 10:17.
21. Del Prete S, Isik S, Vullo D, et al. DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 2012;55: 10742-8.
22. Guzel O, Maresca A, Hall RA, et al. Carbonic anhydrase inhibitors. The beta-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem Lett 2010;20:2508-11.
23. Mitchell AP. Fungal CO2 sensing: A breath of fresh air. Curr Biol 2005;15:R934-6.
24. Mogensen EG, Janbon G, Chaloupka J, et al. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot Cell 2006;5:103-11.
25. Klengel T, Liang WJ, Chaloupka J, et al. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr Biol 2005;15:2021-6.
26. Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase activation and the drug design. Curr Pharm Des 2008;14:708-15.
27. Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active gamma-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett 2013;23:4067-71.
28. Zimmerman SA, Tomb JF, Ferry JG. Characterization of CamH from Methanosarcina thermophila, founding member of a subclass of the {gamma} class of carbonic anhydrases. J Bacteriol 2010;192: 1353-60.
29. Macauley SR, Zimmerman SA, Apolinario EE, et al. The archetype gamma-class carbonic anhydrase (Cam) contains iron when synthesized in vivo. Biochemistry 2009;48:817-19.
30. Pena KL, Castel SE, De Araujo C, et al. Structural basis of the oxidative activation of the carboxysomal gamma-carbonic anhydrase, CcmM. Proc Natl Acad Sci U S A 2010;107:2455-60.
31. Mount DW, ed. Sequence database searching for similar sequences. Chapter 6. In Bioinformatics: Sequence and genome analysis. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor; 2004.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
33. Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004;32:1792-7.
34. Guindon S, Delsuc F, Dufayard JF, Gascuel O. Estimating maximum likelihood phylogenies with PhyML. Methods Mol Biol 2009;537: 113-37.
35. Chirica LC, Elleby B, Jonsson BH, Lindskog S. The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 1997;244:755-60.
36. Capasso C, De Luca V, Carginale V, et al. Biochemical properties of a novel and highly thermostable bacterial alpha-carbonic anhydrase from Sulfurihydrogenibium yellowstonense YO3AOP1. J Enzyme Inhib Med Chem 2012;27:892-7.
37. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561-73.
38. Carta F, Temperini C, Innocenti A, et al. Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem 2010;53:5511-22.
39. Tripp BC, Ferry JG. A structure-function study of a proton transport pathway in the gamma-class carbonic anhydrase from Methanosarcina thermophila. Biochemistry 2000;39:9232-40.
40. Zimmerman SA, Ferry JG, Supuran CT. Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. Curr Top Med Chem 2007;7:901-8.
41. Vullo D, Leewattanapasuk W, Muhlschlegel FA, et al. Carbonic anhydrase inhibitors: Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides. Bioorg Med Chem Lett 2013;23: 2647-52.
42. Vullo D, Isik S, Del Prete S, et al. Anion inhibition studies of the alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem Lett 2013;23:1636-8.
43. Maresca A, Vullo D, Scozzafava A, Supuran CT. Inhibition of the alpha- And beta-carbonic anhydrases from the gastric pathogen Helicobacter pylori with anions. J Enzyme Inhib Med Chem 2013; 28:388-91.
44. Del Prete S, De Luca V, Scozzafava A, et al. Biochemical properties of a new alpha-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae. J Enzyme Inhib Med Chem 2013. doi: 10.3109/14756366.2012.747197.
45. Migliardini F, De Luca V, Carginale V, et al. Biomimetic CO(2) capture using a highly thermostable bacterial alphacarbonic anhydrase immobilized on a polyurethane foam. J Enzyme Inhib Med Chem 2013 doi:10.3109/14756366.2012. 761608.
46. Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs - Antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem 2013. doi:10.3109/14756366.2013.787422.
47. Supuran CT. Enzyme inhibition and more - A tribute to John Smith. J Enzyme Inhib Med Chem 2011;26:301-2.
48. Ozensoy O, Arslan M, Supuran CT. Carbonic anhydrase inhibitors: Purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides. J Enzyme Inhib Med Chem 2011;26:749-53.
49. Vullo D, De Luca V, Scozzafava A, et al. The extremoalpha- carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides. Bioorg Med Chem 2013. doi:10.1016/j.bmc.2013.05.042.
50. Di Fiore A, Capasso C, De Luca V, et al. X-ray structure of the first 'extremo-Alpha-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Acta Crystallogr D Biol Crystallogr 2013;69: 1150-9.
51. Vullo D, De Luca V, Scozzafava A, et al. The first activation study of a bacterial carbonic anhydrase (CA). The thermostable alpha-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. Bioorg Med Chem Lett 2012; 22:6324-7.
52. Vullo D, Luca VD, Scozzafava A, et al. The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides. Bioorg Med Chem 2013;21:1534-8.
53. De Luca V, Vullo D, Scozzafava A, et al. Anion inhibition studies of an alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Bioorg Med Chem Lett 2012;22:5630-4.
54. Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: A patent and literature review. Expert Opin Ther Pat 2013;23: 693-704.
55. Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72.